Rare leukemia study aims to unlock secrets of T-PLL
NCT ID NCT04411043
First seen Jan 10, 2026 · Last updated May 08, 2026 · Updated 16 times
Summary
This study gathers information from 50 people with a rare and aggressive blood cancer called T-cell prolymphocytic leukemia (T-PLL). Researchers will look at patients' medical records, lab results, and genetic data to better understand the disease and how it responds to current treatments. The goal is to improve future care, but no new treatment is being tested in this study.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROLYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chd Le Mans
RECRUITINGLe Mans, 72000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.